{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:17:23Z","timestamp":1790252243068,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,1,4]],"date-time":"2012-01-04T00:00:00Z","timestamp":1325635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007652","name":"Singapore Millennium Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007652","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.biopsych.2011.12.023","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T05:16:47Z","timestamp":1329974207000},"page":"538-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["COMT Val158Met Genotype Determines the Direction of Cognitive Effects Produced by Catechol-O-Methyltransferase Inhibition"],"prefix":"10.1016","volume":"71","author":[{"given":"Sarah M.","family":"Farrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Tunbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Braeutigam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2011.12.023_bib1","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/376572a0","article-title":"Modulation of memory fields by dopamine D1 receptors in prefrontal cortex","volume":"376","author":"Williams","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2011.12.023_bib2","series-title":"Principles of Frontal Lobes Function","first-page":"51","article-title":"Neurochemical modulation of prefrontal cortical function in humans and animals","author":"Arnsten","year":"2002"},{"key":"10.1016\/j.biopsych.2011.12.023_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.051508.135535","article-title":"The neuropsychopharmacology of fronto-executive function: Monoaminergic modulation","volume":"32","author":"Robbins","year":"2009","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.biopsych.2011.12.023_bib4","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.biopsych.2011.03.028","article-title":"Inverted-U-shaped dopamine actions on human working memory and cognitive control","volume":"69","author":"Cools","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0006-3223(01)01252-5","article-title":"Prefrontal neurons and the genetics of schizophrenia","volume":"50","author":"Weinberger","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib6","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/sj.npp.1300542","article-title":"The catechol-O-methyltransferase polymorphism: Relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes","volume":"29","author":"Bilder","year":"2004","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2011.12.023_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biopsych.2005.10.024","article-title":"Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond","volume":"60","author":"Tunbridge","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.biopsych.2008.05.015","article-title":"The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-O-methyltransferase genotypes and schizophrenia","volume":"64","author":"Durstewitz","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuroscience.2009.05.014","article-title":"Genes, cognition and brain through a COMT lens","volume":"164","author":"Dickinson","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2011.12.023_bib10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/425589","article-title":"Functional analysis of genetic variation in catechol-o-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain","volume":"75","author":"Chen","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biopsych.2011.12.023_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/mp.2008.19","article-title":"COMT genotype predicts cortical-limbic D1 receptor availability measured with [C-11]NNC112 and PET","volume":"13","author":"Slifstein","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib12","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1073\/pnas.111134598","article-title":"Effect of COMT Val108\/158 Met genotype on frontal lobe function and risk for schizophrenia","volume":"98","author":"Egan","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2011.12.023_bib13","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/mp.2009.36","article-title":"Neural substrates of pleiotropic action of genetic variation in COMT: A meta-analysis","volume":"15","author":"Mier","year":"2009","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biopsych.2007.03.031","article-title":"Genetic variation in catechol-O-methyltransferase: Effects on working memory in schizophrenic patients, their siblings, and healthy controls","volume":"63","author":"Diaz-Asper","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biopsych.2008.01.005","article-title":"Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene val158\/108met polymorphism","volume":"64","author":"Barnett","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib16","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1523\/JNEUROSCI.1124-04.2004","article-title":"Catechol-O-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex","volume":"24","author":"Tunbridge","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2011.12.023_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-008-1342-1","article-title":"Tolcapone enhances food-evoked dopamine efflux and executive memory processes mediated by the rat prefrontal cortex","volume":"202","author":"Lapish","year":"2009","journal-title":"Psychopharmacol"},{"key":"10.1016\/j.biopsych.2011.12.023_bib18","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/BF01285556","article-title":"Cognitive improvement during tolcapone treatment in Parkinson's disease","volume":"104","author":"Gasparini","year":"1997","journal-title":"J Neural Transm"},{"key":"10.1016\/j.biopsych.2011.12.023_bib19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/sj.npp.1301227","article-title":"Tolcapone improves cognition and cortical information processing in normal human subjects","volume":"32","author":"Apud","year":"2007","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2011.12.023_bib20","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1038\/npp.2008.82","article-title":"Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val(158)Met polymorphism","volume":"33","author":"Giakoumaki","year":"2008","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2011.12.023_bib21","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.biopsych.2009.07.008","article-title":"Tolcapone effects on gating, working memory, and mood interact with the synonymous catechol-O-methyltransferase rs4818C\/G polymorphism","volume":"66","author":"Roussos","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib22","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1073\/pnas.0931309100","article-title":"Catechol O-methyltransferase val(158)-met genotype and individual variation in the brain response to amphetamine","volume":"100","author":"Mattay","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2011.12.023_bib23","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.biopsych.2004.08.012","article-title":"Catechol-O-methyltransferase Val108\/158Met genotype predicts working memory response to antipsychotic medications","volume":"56","author":"Weickert","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib24","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/ajmg.b.30704","article-title":"Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children","volume":"147B","author":"Kereszturi","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.biopsych.2011.12.023_bib25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0009-9236(95)90035-7","article-title":"Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans","volume":"57","author":"Dingemanse","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2011.12.023_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/syn.10034","article-title":"18F-dopa PET evidence that tolcapone acts as a central COMT inhibitor in Parkinson's disease","volume":"43","author":"Ceravolo","year":"2002","journal-title":"Synapse"},{"issue":"suppl","key":"10.1016\/j.biopsych.2011.12.023_bib27","first-page":"S31","article-title":"Pharmacokinetics, pharmacodynamics, and tolerability of tolcapone: A review of early studies in volunteers","volume":"50","author":"Jorga","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2011.12.023_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/syn.10286","article-title":"Catechol-o-methyltransferase and proline dehydrogenase messenger RNA in the prefrontal cortex in schizophrenia, bipolar disorder and major depression","volume":"51","author":"Tunbridge","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2011.12.023_bib29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0893-133X(97)00096-1","article-title":"Functional magnetic resonance imaging brain mapping in psychiatry: Methodological issues illustrated in a study of working memory in schizophrenia","volume":"18","author":"Callicott","year":"1998","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2011.12.023_bib30","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1126\/science.1066893","article-title":"The medial frontal cortex and the rapid processing of monetary gains and losses","volume":"295","author":"Gehring","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2011.12.023_bib31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.biopsych.2009.01.006","article-title":"Genetic variability in the dopamine system (dopamine receptor D4, COMT) modulates neurophysiological responses to gains and losses","volume":"66","author":"Marco-Pallar\u00e9s","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib32","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.neuroimage.2008.06.019","article-title":"Catechol-O-methyltransferase val(158)met genotype influences neural processing of reward anticipation","volume":"42","author":"Schmack","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2011.12.023_bib33","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/cercor\/bhp263","article-title":"The effects of COMT (Val108\/158Met) and DRD4 (SNP-521) dopamine genotypes on brain activations related to valence and magnitude of rewards","volume":"20","author":"Camara","year":"2010","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.biopsych.2011.12.023_bib34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.mp.4001860","article-title":"Impact of complex genetic variation on COMT on human brain function","volume":"11","author":"Meyer-Lindenberg","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib35","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1126\/science.1131262","article-title":"Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure","volume":"314","author":"Nackley","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2011.12.023_bib36","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1523\/JNEUROSCI.6631-10.2011","article-title":"Stress-related methylation of the catechol-O-methyltransferase val(158) allele predicts human prefrontal cognition and activity","volume":"31","author":"Ursini","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2011.12.023_bib37","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1523\/JNEUROSCI.4975-05.2006","article-title":"Additive effects of genetic variation in dopamine regulating genes on working memory cortical activity in humans","volume":"26","author":"Bertolino","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2011.12.023_bib38","doi-asserted-by":"crossref","first-page":"16311","DOI":"10.1073\/pnas.0706111104","article-title":"Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning","volume":"104","author":"Frank","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2011.12.023_bib39","doi-asserted-by":"crossref","first-page":"13600","DOI":"10.1073\/pnas.0903007106","article-title":"Epistasis between the DAT 3\u2032 UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia","volume":"106","author":"Prata","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2011.12.023_bib40","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archpsyc.60.9.889","article-title":"Executive subprocesses in working memory: Relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia","volume":"60","author":"Goldberg","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1017\/S003329171000098X","article-title":"Effects of two dopamine-modulating genes (DAT1 9\/10 and COMT Val\/Met) on n-back working memory performance in healthy volunteers","volume":"41","author":"Blanchard","year":"2011","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2011.12.023_bib42","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.biopsych.2008.07.032","article-title":"The role of COMT Val158Met in cognition","volume":"65","author":"Goldman","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib43","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1038\/sj.npp.1301543","article-title":"Catechol-O-methyltransferase (COMT): A gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders","volume":"33","author":"Harrison","year":"2008","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2011.12.023_bib44","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1523\/JNEUROSCI.6394-10.2011","article-title":"Estrogen shapes dopamine-dependent cognitive processes: Implications for women's health","volume":"31","author":"Jacobs","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2011.12.023_bib45","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/cercor\/bhl032","article-title":"Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan","volume":"17","author":"Tunbridge","year":"2007","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.biopsych.2011.12.023_bib46","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.biopsych.2011.02.027","article-title":"Influence of the COMT genotype on working memory and brain activity changes during development","volume":"70","author":"Dumontheil","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib47","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.1073\/pnas.0702029104","article-title":"Gene-gene interaction associated with neural reward sensitivity","volume":"104","author":"Yacubian","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2011.12.023_bib48","doi-asserted-by":"crossref","first-page":"17951","DOI":"10.1073\/pnas.0905191106","article-title":"Genetic variation in dopaminergic neuromodulation influences the ability to rapidly and flexibly adapt decisions","volume":"106","author":"Krugel","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2011.12.023_bib49","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/npp.2010.96","article-title":"Neurogenetics and pharmacology of learning, motivation, and cognition","volume":"36","author":"Frank","year":"2011","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2011.12.023_bib50","unstructured":"Tunbridge EM, Huber A, Farrell SM, Stumpenhorst K, Harrison PJ, Walton M (in press): The role of catechol-O-methyltransferase (COMT) in reward processing and addiction. CNS Neurol Disord Drug Targets."},{"key":"10.1016\/j.biopsych.2011.12.023_bib51","doi-asserted-by":"crossref","first-page":"17460","DOI":"10.1523\/JNEUROSCI.3772-11.2011","article-title":"Dopaminergic modulation of risky decision-making","volume":"31","author":"Simon","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2011.12.023_bib52","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1523\/JNEUROSCI.0476-05.2005","article-title":"Effect of catechol-O-methyltransferase val158met genotype on attentional control","volume":"25","author":"Blasi","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2011.12.023_bib53","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1017\/S0033291708002912","article-title":"Prepulse inhibition of the startle reflex depends on the catechol O-methyltransferase Val158Met gene polymorphism","volume":"38","author":"Roussos","year":"2008","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2011.12.023_bib54","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1523\/JNEUROSCI.1792-04.2005","article-title":"Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex","volume":"25","author":"Smolka","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2011.12.023_bib55","doi-asserted-by":"crossref","first-page":"8709","DOI":"10.1523\/JNEUROSCI.2077-08.2008","article-title":"Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice","volume":"28","author":"Papaleo","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2011.12.023_bib56","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2165\/00023210-200721070-00002","article-title":"Treatment of cognitive deficits associated with schizophrenia: Potential role of catechol-O-methyltransferase inhibitors","volume":"21","author":"Apud","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopsych.2011.12.023_bib57","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2217\/pgs.10.206","article-title":"Tolcapone, COMT polymorphisms and pharmacogenomic treatment of schizophrenia","volume":"12","author":"Bitsios","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.biopsych.2011.12.023_bib58","doi-asserted-by":"crossref","first-page":"34752","DOI":"10.1074\/jbc.M111.262790","article-title":"Orientation and cellular distribution of membrane-bound catechol-O-methyltransferase in cortical neurons","volume":"286","author":"Chen","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2011.12.023_bib59","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/cercor\/11.12.1136","article-title":"Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands","volume":"11","author":"Cools","year":"2001","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.biopsych.2011.12.023_bib60","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mds.20118","article-title":"Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism","volume":"19","author":"Foltynie","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.biopsych.2011.12.023_bib61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.biopsych.2008.09.027","article-title":"Opposite effects of COMT Val158Met on cortical function in healthy subjects and patients with schizophrenia","volume":"65","author":"Prata","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.12.023_bib62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tics.2010.11.002","article-title":"Cognitive enhancement by drugs in health and disease","volume":"15","author":"Husain","year":"2011","journal-title":"Trends Cogn Sci"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632231101273X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632231101273X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:59:41Z","timestamp":1762099181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000632231101273X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S000632231101273X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2011.12.023","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COMT Val158Met Genotype Determines the Direction of Cognitive Effects Produced by Catechol-O-Methyltransferase Inhibition","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2011.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Society of Biological Psychiatry. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}